Publications

Staniek J, Rizzi M. 2025. Signaling Activation and Modulation in Extrafollicular B Cell Responses. Immunol Rev. 330(1):e70004. doi: 10.1111/imr.70004.

Lösslein AK, Henneke P. 2025. Macrophage Differentiation and Metabolic Adaptation in Mycobacterial Infections. 2025. Annu Rev Immunol. doi: 10.1146/annurev-immunol-082323-120757.

Felixberger PT, Andrieux G, Maul-Pavicic A, Goldacker S, Harder I, Gutenberger S, Landry JJM, Benes V, Jakob TF, Boerries M, Nitschke L, Voll RE, Warnatz K, Keller B. 2025. CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation. Front Immunol. 16:1512279. doi: 10.3389/fimmu.2025.1512279.

Chandrasekaran P, Krausz M, Han Y, Mitsuiki N, Gabrysch A, Nöltner C, Proietti M, Heller T, Grou C, Calderon V, Subramanian P, Jones DR, Siu Y, Deming C, Conlan S, Holland SM, Segre JA, Uzel G, Grimbacher B, Falcone EL. 2025. The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency. Microbiome. 13(1):51. doi: 10.1186/s40168-025-02028-7.

Braun LM, Giesler S, Andrieux G, Riemer R, Talvard-Balland N, Duquesne S, Rückert T, Unger S, Kreutmair S, Zwick M, Follo M, Hartmann A, Osswald N, Melchinger W, Chapman S, Hutchinson JA, Haferkamp S, Torster L, Kött J, Gebhardt C, Hellwig D, Karantzelis N, Wallrabenstein T, Lowinus T, Yücel M, Brehm N, Rawluk J, Pfeifer D, Bronsert P, Rogg M, Mattern S, Heikenwälder M, Fusco S, Malek NP, Singer S, Schmitt-Graeff A, Ceteci F, Greten FR, Blazar BR, Boerries M, Köhler N, Duyster J, Ihorst G, Lassmann S, Keye P, Minguet S, Schadendorf D, Ugurel S, Rafei-Shamsabadi D, Thimme R, Hasselblatt P, Bengsch B, Schell C, Pearce EL, Meiss F, Becher B, Funke-Lorenz C, Placke JM, Apostolova P, Zeiser R. 2025. Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity. Cancer Cell. 2025 Feb 10;43(2):269-291.e19. doi: 10.1016/j.ccell.2025.01.004.

Nyström A. 2025. Dystrophic epidermolysis bullosa – From biochemistry to interventions. Matrix Biol. 2025 Apr;136:111-126. doi: 10.1016/j.matbio.2025.02.001.

Mansoori Moghadam Z, Zhao B, Raynaud C RWTH University Hospital, Strohmeier V, Neuber J, Lösslein AK, Qureshi S, Gres V, Ziegelbauer T, Baasch S, Schell C, Warnatz K, Inohara N, Nunez G, Clavel T, Rosshart SP, Kolter J, Henneke P. 2025. Reactive oxygen species regulate early development of the intestinal macrophage-microbiome interface. Blood. blood.2024025240. doi: 10.1182/blood.2024025240.

Hinz F, Friedel D, Korshunov A, Ippen FM, Bogumil H, Banan R, Brandner S, Hasselblatt M, Boldt HB, Dirse V, Dohmen H, Aronica E, Brodhun M, Broekman MLD, Capper D, Cherkezov A, Deng MY, van Dis V, Felsberg J, Frank S, French PJ, Gerlach R, Göbel K, Goold E, Hench J, Kantelhardt S, Kohlhof-Meinecke P, Krieg S, Mawrin C, Morrison G, Mühlebner A, Ozduman K, Pfister SM, Poliani PL, Prinz M, Reifenberger G, Riemenschneider MJ, Sankowski R, Schrimpf D, Sill M, Snuderl M, Verdijk RM, Voisin MR, Wesseling P, Wick W, Reuss DE, von Deimling A, Sahm F, Maas SLN, Suwala AK. 2025. IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread. Acta Neuropathol. 149(1):12. doi: 10.1007/s00401-025-02849-8.

Wang Y, Hess ME, Tan Y, Esser PR, Nyström A, Boerries M, Sayar SB, Has C. 2025. Alterations in the microenvironment of junctional epidermolysis bullosa keratinocytes: A gene expression study. 2025. Matrix Biol. Feb;135:12-23. doi: 10.1016/j.matbio.2024.11.005.

Posadas-Cantera S, Mitsuiki N, Emmerich F, Patiño V, Lorenz HM, Neth O, Dybedal I, Taskén K, Schäffer AA, Grimbacher B, Gámez-Díaz L. 2025. The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency. Front Immunol. 15:1447995. doi: 10.3389/fimmu.2024.1447995.

Bruno P, Schüler T, Rosshart SP.2025. Born to be wild: utilizing natural microbiota for reliable biomedical research. Trends Immunol. 2025 Jan;46(1):17-28. doi: 10.1016/j.it.2024.11.013.

Giorgetti OB, Haas-Assenbaum A, Boehm T. 2025. Probing TCR Specificity Using Artificial In Vivo Diversification of CDR3 Regions. Eur J Immunol. 55(1):e202451434. doi: 10.1002/eji.202451434.

Drude N, Nagel-Riedasch S, Rosshart SP, Diefenbach A; “Charité 3R Wildling Mouse Model in Health and Disease (C3R Wildling HeaD)” consortium; 2024. A facility for laboratory mice with a natural microbiome at Charité – Universitätsmedizin Berlin. Jordan S.Lab Anim (NY). 53(12):351-354. doi: 10.1038/s41684-024-01474-4.

Bruno P, Schüler T, Rosshart SP. 2024. Born to be wild: utilizing natural microbiota for reliable biomedical research. Trends Immunol. 46(1):17-28. doi: 10.1016/j.it.2024.11.013.

Ankerhold J, Kessler S, Beer M, Schwemmle M, Ciminski K. 2025. Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023-2024. Emerg Infect Dis. Jan;31(1):199-202. doi: 10.3201/eid3101.241236.

Wang Y, Hess ME, Tan Y, Esser PR, Nyström A, Boerries M, Sayar SB, Has C. 2025. Alterations in the microenvironment of junctional epidermolysis bullosa keratinocytes: A gene expression study. Matrix Biol. 35:12-23. doi: 10.1016/j.matbio.2024.11.005.